FDA (CDER)
GUIDANCE DRAFT
Q3E Guideline for Extractables and Leachables: Supporting Documentation: Class 3 Leachable Monographs
Published: 11/28/2025Detected: 3/20/2026
Summary preview
Clarifies the supporting documentation expectations under ICH Q3E for extractables and leachables assessments, with specific monographs intended to support Class 3 leachables qualification.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
safety
#extractables and leachables
#ICH Q3E
#container closure system
#leachable monographs
#Class 3 leachables
Official Source Document Source Verified
Access the original document directly from FDA CDER.
More from FDA (CDER)
- E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential--Questions and Answers (R1): Guidance for Industry10/30/2026
- Submitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle10/20/2026
- Regulatory Considerations for Prescription Drug Use-Related Software10/20/2026
- Safety Reporting Requirements for INDs and BA/BE Studies: Guidance for Industry and Investigators10/19/2026
- Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers10/9/2026